Effects of Electronic Cigarette Flavors on Abuse Liability in Smokers (P3-Taste)
2 other identifiers
interventional
40
1 country
1
Brief Summary
The purpose of this study is to determine if abuse liability indices will be impacted by varying flavors and e-cigarette (ECIG) nicotine delivery capability (i.e., nicotine flux) among current combustible cigarette users. The investigators will compare abuse liability indices between three FDA-authorized ECIG products that vary in nicotine flux (but are all tobacco flavor) and own brand cigarettes. The investigators will also test the influence of ECIG flavor availability (tobacco vs. menthol) within three ECIG product classes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 14, 2023
CompletedStudy Start
First participant enrolled
July 31, 2023
CompletedFirst Posted
Study publicly available on registry
August 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 26, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 26, 2024
CompletedOctober 2, 2024
September 1, 2024
12 months
July 14, 2023
September 30, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Breakpoint of Drug Purchase Task (DPT)
The DPTs will yield measures of willingness to pay and measures of price sensitivity for session-specific tobacco products. Choices made during this task are not reinforced during the session.
Each DPT will be completed twice per study session, about 55 minutes into the session and again at 120 minutes into the session
Elasticity of Drug Purchase Task (DPT)
The DPTs will yield measures of willingness to pay and measures of price sensitivity for session-specific tobacco products. Choices made during this task are not reinforced during the session.
Each DPT will be completed twice per study session, about 55 minutes into the session and again at 120 minutes into the session
Omax of Drug Purchase Task (DPT)
The DPTs will yield measures of willingness to pay and measures of price sensitivity for session-specific tobacco products. Choices made during this task are not reinforced during the session.
A DPT will be Each DPT will be completed twice per study session, about 55 minutes into the session and again at 120 minutes into the session once for each arm.
Pmax of Drug Purchase Task (DPT)
The DPTs will yield measures of willingness to pay and measures of price sensitivity for session-specific tobacco products. Choices made during this task are not reinforced during the session.
Each DPT will be completed twice per study session, about 55 minutes into the session and again at 120 minutes into the session
Intensity of Drug Purchase Task (DPT)
The DPTs will yield measures of willingness to pay and measures of price sensitivity for session-specific tobacco products. Choices made during this task are not reinforced during the session.
Each DPT will be completed twice per study session, about 55 minutes into the session and again at 120 minutes into the session
Cross-price elasticity of the Cross Product-DPT
The Cross Product (CP)-DPTs assess cross-product purchasing behaviors between various tobacco products offered at a fixed amount and own brand cigarettes offered at varying prices.
Each CP-DPT will be completed twice per study session, about 55 minutes into the session and again at 120 minutes into the session
Other Outcomes (6)
Subjective measures of nicotine withdrawal
Up to 55 minutes (session 1) and up to 120 minutes (sessions 2-4) into the session
Subjective measures of nicotine side effects
Up to 55 minutes (session 1) and up to 120 minutes (sessions 2-4) into the session
Subjective measures of product effects
Up to 55 minutes (session 1) and up to 120 minutes (sessions 2-4) into the session
- +3 more other outcomes
Study Arms (7)
Own Brand Cigarette
ACTIVE COMPARATORNJOY Ace 2.4% nicotine ECIG - Menthol flavor
EXPERIMENTALNJOY Ace 2.4% nicotine ECIG - Classic Tobacco flavor
EXPERIMENTALNJOY Ace 5.0% nicotine ECIG - Menthol flavor
EXPERIMENTALNJOY Ace 5.0% nicotine ECIG - Classic Tobacco flavor
EXPERIMENTALNJOY Daily 6.0% nicotine ECIG - Menthol flavor
EXPERIMENTALNJOY Daily 6.0% nicotine ECIG - Extra Rich Tobacco flavor
EXPERIMENTALInterventions
Subjective measures 1 is followed by product sampling that includes 5 self-directed ECIG/own brand cigarette puffs over 10 minutes. After sampling is complete participants complete subjective measures 2. Ten minutes after their sampling has been completed, they complete subjective measures 3 and the behavioral economic task(s). These activities are preceded and followed by cardiovascular response assessment.
Eligibility Criteria
You may qualify if:
- healthy (determined by self-report)
- at least 18 years old
- willing to provide informed consent
- able to attend the lab and use designated products according to study protocol
- smoke cigarettes at least 3 days per week and on those days at least 1 cigarette smoked per day
- positive urine cotinine test
You may not qualify if:
- Women if they are breast-feeding or test positive for pregnancy (by urinalysis) at screening.
- Some study details about the eligibility criteria are purposely omitted at this time to preserve scientific integrity. Full details will be posted at the conclusion of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Center for the Study of Tobacco Products
Richmond, Virginia, 23220, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Caroline O Cobb, PhD
Virginia Commonwealth University
- PRINCIPAL INVESTIGATOR
Andrew Barnes, PhD
Virginia Commonwealth University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants will be blinded to device nicotine concentration and flavor used during ECIG sessions. No blinding will occur for the own brand condition.
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 14, 2023
First Posted
August 2, 2023
Study Start
July 31, 2023
Primary Completion
July 26, 2024
Study Completion
July 26, 2024
Last Updated
October 2, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will share